Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.21.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2021
SIGNIFICANT ACCOUNTING POLICIES  
Schedule of calculation of weighted average dilutive common shares

The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

 

 

 

 

 

 

 

 

    

For the Three Months Ended

 

 

 

March 31, 

 

 

    

2021

    

2020

 

Stock options

 

117,261

 

97,856

 

Warrants

 

5,234,721

[1]

1,138,556

 

Convertible notes

 

 0

 

21,519

[2]

 

 

5,351,982

 

1,257,931

 


[1]Includes shares underlying warrants that are exercisable into an aggregate of (i) 462,997 shares of common stock and (ii) five-year warrants to purchase 462,997 shares of common stock at an exercise price of $5.50 per share.

[2]Excludes shares issuable upon conversion of the Senior and Junior Notes, which were not convertible as of March 31 , 2020 and whose conversion price was not known as of such date.